Broadwood Partners, L.P.

Insider Reports History

Entity
Company
Location
Broadwood Capital Inc., 142 West 57 Th Street, 11 Th Floor, New York, New York
Signature
Broadwood Partners, L.P., By: Broadwood Capital, Inc., By: /s/ Neal C. Bradsher, President
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Broadwood Partners, L.P.:

Stock Role Class Num Shares Value Price $ Report Date Ownership
STAAR SURGICAL CO 10%+ Owner Common Stock 10.8M $458M $42.56 May 9, 2024 Direct
STAAR SURGICAL CO 10%+ Owner Common Stock 10.8M $458M $42.56 May 9, 2024 Indirect
Lineage Cell Therapeutics, Inc. Director, 10%+ Owner Common Shares 41.7M $43.3M $1.04 Feb 6, 2024 Direct
Lineage Cell Therapeutics, Inc. Director, 10%+ Owner Common Shares 41.7M $43.3M $1.04 Feb 6, 2024 Indirect
Oncocyte Corp 10%+ Owner Common Stock, no par value 4.93M $14.4M $2.92 Apr 11, 2024 Direct
Oncocyte Corp 10%+ Owner Common Stock, no par value 4.93M $14.4M $2.92 Apr 11, 2024 Indirect
Oncocyte Corp 10%+ Owner Warrant to Purchase Common Stock 150K Apr 11, 2024 Direct
Oncocyte Corp 10%+ Owner Warrant to Purchase Common Stock 150K Apr 11, 2024 Indirect
Oncocyte Corp 10%+ Owner Series A Convertible Preferred Stock 0 Apr 15, 2024 Direct
Oncocyte Corp 10%+ Owner Series A Convertible Preferred Stock 0 Apr 15, 2024 Indirect

Insider Reports Filed by Broadwood Partners, L.P.

Symbol Company Period Transactions Value $ Form Type Date Filed Role
STAA STAAR SURGICAL CO May 9, 2024 2 $42.60 4 May 13, 2024 10%+ Owner
OCX Oncocyte Corp Apr 11, 2024 4 $7.06M 4 Apr 15, 2024 10%+ Owner
LCTX Lineage Cell Therapeutics, Inc. Feb 6, 2024 2 $7M 4 Feb 8, 2024 Director, 10%+ Owner
STAA STAAR SURGICAL CO Jan 8, 2024 2 $110K 4 Jan 10, 2024 10%+ Owner
STAA STAAR SURGICAL CO Jan 3, 2024 8 $6.48M 4 Jan 5, 2024 10%+ Owner
STAA STAAR SURGICAL CO Nov 28, 2023 10 $13.7M 4 Nov 30, 2023 10%+ Owner
STAA STAAR SURGICAL CO Nov 10, 2023 4 $1.14M 4 Nov 14, 2023 10%+ Owner
STAA STAAR SURGICAL CO Nov 7, 2023 8 $9.66M 4 Nov 9, 2023 10%+ Owner
STAA STAAR SURGICAL CO Nov 2, 2023 8 $10.8M 4 Nov 6, 2023 10%+ Owner
STAA STAAR SURGICAL CO Oct 4, 2023 6 $7.76M 4 Oct 6, 2023 10%+ Owner
STAA STAAR SURGICAL CO Sep 19, 2023 6 $11.7M 4 Sep 21, 2023 10%+ Owner
STAA STAAR SURGICAL CO Sep 5, 2023 6 $7.87M 4 Sep 7, 2023 10%+ Owner
OCX Oncocyte Corp Apr 3, 2023 2 $8.09M 4 Apr 5, 2023 10%+ Owner
STAA STAAR SURGICAL CO Dec 27, 2022 6 $9.06M 4 Dec 29, 2022 10%+ Owner
OCX Oncocyte Corp Apr 13, 2022 6 $8M 4 Apr 15, 2022 10%+ Owner
LCTX Lineage Cell Therapeutics, Inc. Mar 23, 2022 6 $1.32M 4 Mar 25, 2022 Director, 10%+ Owner
STAA STAAR SURGICAL CO Oct 1, 2021 2 $0 4 Oct 1, 2021 10%+ Owner
OCX Oncocyte Corp Sep 23, 2021 8 $1.81M 4 Sep 24, 2021 10%+ Owner
STAA STAAR SURGICAL CO Jul 1, 2021 2 $0 4 Jul 2, 2021 10%+ Owner
STAA STAAR SURGICAL CO Jun 24, 2021 6 -$35.7M 4 Jun 28, 2021 10%+ Owner
STAA STAAR SURGICAL CO Jun 16, 2021 6 -$16.2M 4 Jun 21, 2021 10%+ Owner
STAA STAAR SURGICAL CO Jun 11, 2021 6 -$8.79M 4 Jun 15, 2021 10%+ Owner
STAA STAAR SURGICAL CO May 27, 2021 6 -$39.1M 4 Jun 1, 2021 10%+ Owner